Oligonucleotide Manufacturing Market: Global, Annual Demand

by Roots Analysis Roots Analysis provides market research and consul

At present, eight oligonucleotide-based drugs have been approved, while over 200 product candidates are being evaluated in various clinical trials across the globe. As the market for such therapeutic interventions continues to evolve, it is likely to induce a steadily growing demand for oligonucleotides. According to our estimates, the global annual demand for oligonucleotides is growing at an annualized rate of 13.2%, during the period 2020-2030.

 

As per the analysis, more than 65% of the current demand is likely to be driven by commercial oligonucleotide-based products. During the forecast period, the commercial demand for oligonucleotides is anticipated to grow at a CAGR of 14.7%. Further, the demand for antisense oligonucleotides is anticipated to be the highest in the coming years, growing at a CAGR of 9.8% in the given time period. In terms of therapeutic area, the manufacturing demand for oligonucleotides intended for the treatment of neuromuscular disorders is likely to be the highest, growing at a CAGR of 8.1%, in the given time period.

 

 

Further, as per our analysis, the clinical demand for oligonucleotides is likely to grow at a CAGR of 10%, during the period 2020-2030. As indicated earlier, in recent years, a large number of development programs have been initiated in order to evaluate oligonucleotide-based drug products for the treatment of different clinical conditions. As more such studies are expected to start in the coming years, the clinical manufacturing demand for oligonucleotides is expected to rise significantly.

 

It is worth highlighting that over 20% of the current clinical demand is anticipated to be driven by antisense oligonucleotides. However, the clinical demand for miRNAs and siRNAs is likely to grow at a CAGR of 15.9% and 10.4%, respectively. Further, the manufacturing demand for oligonucleotides intended for the treatment of oncological disorders is likely to be the highest in the coming years, growing at a CAGR of 5.2% during the given time period. Further, majority of the current demand for oligonucleotides is anticipated to be concentrated in North America and Europe. Further, the demand in Asia-Pacific and rest of the world is estimated to grow at a CAGR of 11.8% in the given time period.

 

In fact, in an interview with the founder and managing director of a small company, he stated that “Industry players are rapidly upgrading their businesses to meet the demand for therapeutic oligonucleotides.  Further, majority of the GMP manufacturers are focused on increasing their capacity to produce better quality oligonucleotides for various emerging applications.”

 

Complete report by Roots Analysis: Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030

Sponsor Ads

• Ad Space Available - Rent it Now!

Created on Jun 23rd 2020 07:10. Viewed 259 times.

Comments